Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
about
Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 x Brown Norway male rats.Future therapy of portal hypertension in liver cirrhosis - a guess.Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver CirrhosisNovel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.Addressing liver fibrosis with liposomes targeted to hepatic stellate cells.Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension.Managing portal hypertension in patients with liver cirrhosis.Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion
P2860
Q30451313-88FB64D4-0901-4E6E-967F-3E059DC8E6D6Q34446521-2C0B79BC-DEFA-411D-86BE-695397AD4B99Q35787734-09DAD112-F651-4B67-94A1-2192AF6EEF0FQ36121721-6C85FF14-D6CA-4746-8892-FB3F303F4C06Q37363773-7195AE79-D141-48FF-8419-86985D53DFA4Q37692727-5D0C073E-406D-43CC-9F67-9477BF325BABQ40038186-9DA9473E-8F23-4939-B245-572671344424Q41029212-F6150A3B-B2FC-4437-BD27-70C46C09B47EQ43258430-4DAEE0BD-02AB-481F-BC70-F3B0ACCC55FEQ46636382-12074697-4E1E-411A-AC42-80A669402D5BQ46890423-1B647083-BD4A-4A70-AB35-BC00356561BBQ53817185-85B2C97E-FA80-4F70-B7FB-149AA927D792Q53834535-DB9EBF1A-37B4-4D22-8AD4-F7CCFE311836Q55278061-A1081D5D-74C9-4A6B-8228-BF56385D2C42Q57108060-A51FBEF4-C6EF-4704-B614-CAE559340897
P2860
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@en
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@nl
type
label
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@en
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@nl
prefLabel
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@en
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@nl
P2093
P2860
P1433
P1476
Vascular, hemodynamic and rena ...... h secondary biliary cirrhosis.
@en
P2093
Jörg Heller
Markus Neef
Martin Hennenberg
Michael Schepke
Thomas Shiozawa
Tilman Sauerbruch
P2860
P304
P356
10.1111/J.1478-3231.2005.01053.X
P577
2005-06-01T00:00:00Z